1. |
Khim G, Em S, Mo S, et al. Liver abscess: diagnostic and management issues found in the low resource setting. Br Med Bull, 2019, 132(1): 45-52.
|
2. |
Thng CB, Tan YP, Shelat VG. Gas-forming pyogenic liver abscess: A world review. Ann Hepatobiliary Pancreat Surg, 2018, 22(1): 11-18.
|
3. |
Du ZQ, Zhou XC, Zhao JZ, et al. Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization. BMC Infect Dis, 2020, 20(1): 145.
|
4. |
Ko MC, Lin WH, Martini S, et al. A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus. Medicine (Baltimore), 2019, 98(17): e15366.
|
5. |
Chen J, Zhang M, Chen J, et al. Cryptogenic and non-cryptogenic liver abscess: A retrospective analysis of 178 cases revealed distinct characteristics. J Int Med Res, 2018, 46(9): 3824-3836.
|
6. |
Gallagher MC, Andrews MM. Postdischarge outcomes of pyogenic liver abscesses: single-center experience 2007–2012. Open Forum Infect Dis, 2017, 4(3): ofx159.
|
7. |
Neill L, Edwards F, Collin SM, et al. Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess. BMC Infect Dis, 2019, 19(1): 490.
|
8. |
杨娜, 张化冰, 李玉秀. 《美国糖尿病学会2019年版糖尿病医学诊疗标准》更新与解读. 协和医学杂志, 2019, 10(5): 476-480.
|
9. |
中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018). 中国急救医学, 2018, 38(9): 741-756.
|
10. |
齐文旗, 黄椿媚, 边帆, 等. 肝脓肿致脓毒血症的危险因素及早期诊断. 中华急诊医学杂志, 2019, 28(11): 1383-1389.
|
11. |
Li W, Chen H, Wu S, et al. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol, 2018, 18(1): 144.
|
12. |
惠鹏, 朱鹏, 廖威, 等. BLA菌群分布与耐药性分析的多中心回顾性研究(附897例报告). 中华消化外科杂志, 2019, 18(10): 924-933.
|
13. |
Yeh YT, Wang BY, Lin CW, et al. Periodontitis and dental scaling associated with pyogenic liver abscess: A population-based case-control study. J Periodontal Res, 2018, 53(5): 785-792.
|
14. |
Xu J, Zhou X, Zheng C. The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess. BMC Geriatr, 2019, 19(1): 14.
|
15. |
Kim EJ, Ha KH, Kim DJ, et al. Diabetes and the risk of infection: a national cohort study. Diabetes Metab J, 2019, 43(6): 804-814.
|
16. |
马海涛, 陈国宙, 王煊, 等. 2型糖尿病对细菌性肝脓肿病情影响的研究. 中华医院感染学杂志, 2019, 29(9): 1351-1354.
|
17. |
Wang WJ, Tao Z, Wu HL. Etiology and clinical manifestations of bacterial liver abscess: a study of 102 cases. Medicine, 2018, 97(38): e12326.
|
18. |
Ruiz-Hernández JJ, Conde-Martel A, Serrano-Fuentes M, et al. Pyogenic liver abscesses due to Escherichia coli are still related to worse outcomes. Ir J Med Sci, 2020, 189(1): 155-161.
|
19. |
柳涛, 张莉. 《2016年英国国家卫生与临床优化研究所非酒精性脂肪性肝病的评估和管理指南》摘译. 临床肝胆病杂志, 2016, 32(11): 2036-2038.
|
20. |
Lai SW, Lin CL, Liao KF. Population-based cohort study investigating the association between weight loss and pyogenic liver abscesses. BioMedicine, 2017, 7(4): 26.
|
21. |
Lai SW. Early predictors for the diagnosis of pyogenic liver abscess. Intern Emerg Med, 2019, 14(6): 1011-1012.
|
22. |
Hoh CH, Tan YH, Gan YH. Protective role of kupffer cells and macrophages in Klebsiella pneumoniae-induced liver abscess disease. Infect Immun, 2019, 87(9): e00369-e00319.
|
23. |
陈薇, 杨春凤, 曹阳, 等. 肺炎克雷伯菌肝脓肿发病危险因素及致病菌耐药性分析. 中华传染病杂志, 2018, 36(10): 630-634.
|
24. |
Xu S, Wang Y, Chen J, et al. Application of ultrasound-guided percutaneous intrahepatic portal vein catheterization with antibiotic injection for treating unliquefied bacterial liver abscess. Hepatol Res, 2017, 47(3): E187-E192.
|
25. |
廖卫, 刘秉彦, 杨炳昂, 等. 介入性超声在细菌感染性肝脓肿患者中的应用效果研究. 中华医院感染学杂志, 2017, 27(16): 3715-3718.
|
26. |
Miłek T, Ciostek P. Percutaneous treatment of liver abscess–outcomes. Prz Gastroenterol, 2019, 14(2): 129-132.
|